Trump Photo Vanishes from Epstein Document Release
A photo of Donald Trump found in Jeffrey Epstein's files was removed from a DOJ release. House Democrats demand transparency and consider impeachment over the handling of the documents.
Category : Search result: pharmaceutical oversight
Fox Host Debunks Trump's 600% Drug Price Cut Claim
A Fox News anchor delivered a brutal math lesson on air, highlighting the impossibility of Trump's claim about slashing prescription drug prices by 600%. See the reality vs. perception clash unfold.
New Jeffrey Epstein Photos Released Before DOJ Deadline
Democrats on the U.S. House Oversight Committee released over 70 new images from Jeffrey Epstein's estate, including disturbing photos and connections to powerful figures, one day before a legal deadline for full disclosure.
New Epstein Photos Released Ahead of DOJ File Deadline
U.S. House Democrats release 68 new photos from Jeffrey Epstein's estate, increasing pressure on the Trump administration to meet Friday's deadline for disclosing federal files under the new transparency law.
Democrats Release New Batch of Disturbing Epstein Photos
House Oversight Committee Democrats unveil disturbing new images from Jeffrey Epstein's estate, including photos with 'Lolita' text. Updates expected.
Health Canada Approves Drug for Rare Disease
Health Canada has granted approval for a new pharmaceutical treatment targeting a rare disease, offering hope for patients. Learn about the regulatory decision and its impact.
Parry Sound School Construction Delayed Again
Ontario's education minister announces another delay for Parry Sound High School, pledging provincial oversight. Get the latest on the troubled Near North District School Board.
Trump Media Crypto Deal Sparks Conflict of Interest Fears
A proposed deal between Trump Media and a cryptocurrency firm highlights potential conflicts of interest, raising questions about regulatory oversight and investor protection in the evolving digital asset space.
Pfizer 2026 profit forecast below expectations
Pfizer projects 2026 profits below Wall Street estimates due to a steep drop in COVID product sales and loss of exclusivity for key drugs. Get the full business analysis.
Sask. auditor raises red flags over care home inspections
Saskatchewan's auditor finds infrequent and inadequate inspections of care homes, raising serious concerns about resident safety and oversight. Read the full report.
Democrats Release New Photos from Epstein's Private Islands
U.S. House Democrats have released never-before-seen photos and video from Jeffrey Epstein's private islands, calling for full transparency in the investigation. Details inside.
Democrats Release New Photos from Epstein's Islands
U.S. House Democrats release never-before-seen images from Jeffrey Epstein's private islands, calling for full transparency and justice for survivors. Details inside.
New Alberta Police Oversight Body Launches Amid Independence Concerns
Alberta's new Police Review Commission begins operations, but its architect warns it must avoid becoming a 'retirement gig' for former officers to ensure true civilian oversight.
Jack Smith Subpoenaed by House GOP for December Testimony
House Judiciary Committee subpoenas Special Counsel Jack Smith to testify on December 17, 2025, regarding his prosecutions of Donald Trump. Follow for updates.
China's Biopharma Surge Challenges Global Drug Leaders
China's biopharma industry is accelerating, fueled by record investment and streamlined supply chains. With faster development times and massive deals like AstraZeneca's $5.2B pact, the global drug innovation race is heating up. Discover the shift from ou
Alberta's New Police Oversight Body Begins Operations
Alberta's new Police Review Commission, integrating ASIRT, started Monday. It aims to speed up investigations and enhance transparency in police complaints. Learn about the new three-tier complaint system.
Ontario may place more school boards under supervision
Ontario's Education Minister signals readiness to intervene in struggling school boards, vowing to 'put you back on track.' Get the latest on provincial oversight in education.
Eli Lilly cuts price of obesity drug Zepbound
Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.
SIU Investigating Northern Ontario Arrest from October
Ontario's Special Investigations Unit is examining an October arrest in northern Ontario after receiving a formal complaint. Get the latest details on the ongoing probe.
Canada's military civilian oversight too lax: study
New research exposes significant weaknesses in Canada's civilian oversight of military operations. Learn about the findings and what changes experts recommend for stronger accountability.
Boehringer Ingelheim Names New Board Member for IT
Boehringer Ingelheim announces Harsha Deshmukh's appointment to Board of Managing Directors for IT and Global Business Services effective February 2026.
Comer's Epstein Probe Backfires, Exposing Trump
House Oversight Chair James Comer's aggressive investigation into Jeffrey Epstein has unearthed damaging documents, creating political fallout for Donald Trump and fracturing the Republican party.
Grey Bruce drug disposal nets meds for hockey tickets
Grey Bruce residents exchanged unused pharmaceuticals for Barrie Colts hockey tickets in a successful medication safety initiative. Learn how this program helps combat opioid misuse and environmental contamination.
Dipharma's Novel Method Detects Nitrosamine Risks
Dipharma publishes a peer-reviewed study unveiling a novel method to detect and characterize nitrosamine impurities in Active Pharmaceutical Ingredients, enhancing drug safety and regulatory compliance.
Epstein Victims' Names Exposed in DOJ Document Release
Jeffrey Epstein survivors face widespread panic as the DOJ releases unredacted files, exposing their identities. Lawyers demand justice and privacy protection. Read the full report.
Novo Nordisk Alzheimer's Drug Trials Fail
Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.
India probes cough syrup deaths amid safety concerns
Indian officials are investigating whether safety failures led to children dying from contaminated cough syrup. Get the latest details on this developing health crisis.
Eli Lilly Reaches $1 Trillion Valuation Milestone
Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.
Denmark compensates for Novo Nordisk vision loss
Danish authorities provide compensation to patients experiencing vision loss linked to Novo Nordisk medications. Learn about the pharmaceutical safety developments affecting Canadian consumers.
Teva Launches Global Innovation Platform for Pharma Breakthroughs
Teva Pharmaceutical launches Rise, a global open innovation platform connecting startups with pharma challenges in AI, digital health and smart manufacturing to accelerate patient impact.
Page 1 of 3